SCHEMBL7130500

SCHEMBL7130500

O=[N+]([O-])c1cccc(Nc2nccc3c(-c4ccccc4)cccc23)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 15/20 0.63
PDE5A O76074 1/20 0.60
ALDH1A1 P00352 2/20 0.54
KMT2A Q03164 2/20 0.54
KDM4E B2RXH2 1/20 0.54
GLA P06280 1/20 0.54
POLB P06746 1/20 0.54
GAA P10253 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
PTK6 Q13882 1/20 0.53
MEN1 O00255 1/20 0.52
NPC1 O15118 1/20 0.52
MAPT P10636 1/20 0.52
RAB9A P51151 1/20 0.52
KCNH2 Q12809 1/20 0.52
ABL1 P00519 1/20 0.50
EGFR P00533 1/20 0.50
BCR P11274 1/20 0.50
SRC P12931 1/20 0.50
PRKCA P17252 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5445534 0.86 ABCG2 (0.52) ABCG2PDE5AKMT2APTK6MEN1
SCHEMBL7120233 0.83 ABCG2 (0.59) ABCG2PDE5AALDH1A1KMT2AKDM4E
SCHEMBL4527890 0.83 CA2 (0.50) ABCG2PDE5AALDH1A1KMT2AKDM4E
SCHEMBL14574524 0.83 ABCG2 (0.54) ABCG2PDE5AALDH1A1KMT2AGAA
SCHEMBL7125170 0.83 ABCG2 (0.65) ABCG2PDE5AALDH1A1KMT2AKDM4E
SCHEMBL7127026 0.80 AHR (0.53) ABCG2PDE5AALDH1A1KMT2AKDM4E
SCHEMBL7125162 0.79 ABCG2 (0.57) ABCG2PDE5AALDH1A1KMT2AKDM4E
SCHEMBL29287173 0.77 KMT2A (0.60) ABCG2PDE5AALDH1A1KMT2AKDM4E
SCHEMBL13632607 0.76 MAPKAPK2 (0.52) ALDH1A1KMT2AGAASMN1; SMN2MEN1
SCHEMBL7120224 0.76 SYK (0.44) ABCG2PDE5AALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030176454-A1 N-coating heterocyclic compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-09-18 US disclosed
WO-2001087845-A2 N-CONTAINING HETEROCYCLIC COMPOUNDS AND THEIR USE AS 5-HT ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030176454-A1 N-coating heterocyclic compounds H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, GNE, NIT2 ABCG2 639/4885PDE5A 3046/4885ALDH1A1 2482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.